Market Dynamics of Infertility Treatment in India: A Comprehensive Analysis

Indian infertility diagnosis and treatment market is anticipated to grow at a CAGR of 12.5% during the forecast period (2024–2031). The rising consumption of alcohol, and cigarette consumption drives the market as consumption of these noxious substances decreases the quality of sperm which leads to infertility. This trend is further worsened by a rapidly increasing number of women engaging in binge and hazardous drinking. 

In addition, infertility cases have grown due to the rising trend of delayed parenthood. This is prompting individuals to go in for advanced treatment options, attributing to the declining egg quality among women, thus making it difficult to conceive. In addition, sedentary lifestyles have increased the number of infertility cases. As a result, more individuals are opting for advanced treatment options, which is creating huge opportunities in the market.

Browse the full report description of “Indian Infertility Diagnosis and Treatment Market Size, Share & Trends Analysis Report by Female Infertility Diagnosis (Ovulation Testing, Hysterosalpingography, Hysteroscopy, Imaging Testing, Ovarian Reserve Testing, Hormonal Level Testing, Genetic Testing, and Others), by Male Infertility Diagnosis (Semen Analysis, Genetic Testing, Testicular Biopsy, Hormone Testing, and Others), and by Infertility Treatment (Drugs and Medicine, Surgical Interventions, Assisted Reproductive Technology (ART), and Others) Forecast Period (2024-2031)” at https://www.omrglobal.com/industry-reports/indian-infertility-market

Factors such as decreasing fertility rates, rising acceptance of infertility treatment, rising private and public investments, and the presence of advanced infertility treatment are expected to propel market growth.  Lower fertility services costs in emerging markets such as India facilitate health tourism and further stimulate market expansion. 

Recent Developments

• In January 2022, Apollo Fertility, a part of the Apollo Health & Lifestyle and Apollo Hospitals group, announced its expansion into Northern India with the establishment of its first, state-of-the-art standalone fertility Centre in Noida bringing a ray of hope to couples who are unable to conceive naturally.

Market Coverage  

· The market number available for 2023-2031 

· Base year: 2023 

· Forecast period: 2024-2031 

· Segment Covered- 

o By Female Infertility Diagnosis 

o By Male Infertility Diagnosis

o By Infertility Treatment 

• Competitive Landscape: Dr. Reddy’s Laboratories Ltd., Lupin Ltd., Sun Pharmaceutical Industries Ltd., Cipla Ltd., and Intas Pharmaceuticals Ltd., among others.

Key questions addressed by the report 

• What is the market's growth rate? 
• Which segment dominates the market in the base year? 
• Which segment will project the fastest growth in the market? 
• Who is the leader in the market? 
• How are players addressing challenges to sustain growth? 
• Where is the investment opportunity? 

Indian Infertility Diagnosis and Treatment Market Report Segment 

By Female Infertility

• Ovulation Testing
• Hysterosalpingography
• Hysteroscopy
• Imaging Testing
• Ovarian Reserve testing
• Hormonal Level Testing
• Genetic Testing 
• Others (Thyroid Function Tests)

By Male Infertility

• Semen Analysis
• Genetic Testing
• Testicular Biopsy
• Hormone Testing
• Others (Imaging Techniques, and Anti-Sperm Antibody Testing)

By Infertility Treatment 

• Drugs and Medicine 
• Surgical
• Assisted Reproductive Technology (ART)
• Others 

 To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/indian-infertility-market